NR 507 Edapt Week 7 Exam – 180 Questions on Neurodegenerative Disorders, Multiple Sclerosis, Guillain-Barré & Myasthenia Gravis – 2026

This document contains a comprehensive 180-question exam review for NR 507 Edapt Week 7, focusing on neurodegenerative, demyelinating, neuromuscular, and peripheral nerve disorders. The content thoroughly covers Alzheimer’s disease (amyloid-beta plaques, tau tangles, APOE alleles, MMSE screening, stages of cognitive decline, definitive diagnosis at autopsy), Parkinson’s disease (substantia nigra degeneration, dopamine deficiency, pill-rolling tremor, bradykinesia, rigidity, levodopa/carbidopa therapy, deep brain stimulation), Huntington’s disease, ALS, and Lewy Body Dementia. Risk factors, genetic influences, neuroinflammation, mitochondrial dysfunction, and multidisciplinary care approaches are emphasized throughout. Extensive detail is provided on Multiple Sclerosis pathophysiology (inflammation, demyelination, gliosis, neurodegeneration), McDonald Criteria, MRI findings, CSF oligoclonal bands, Uhthoff’s phenomenon, relapsing-remitting versus primary progressive MS, and pharmacologic management including corticosteroids and immune modulators. Guillain-Barré Syndrome is reviewed in depth, including albuminocytologic dissociation, molecular mimicry, IVIG and plasmapheresis treatment, respiratory monitoring, autonomic dysfunction, and rehabilitation strategies. Myasthenia gravis is also comprehensively addressed, covering acetylcholine receptor antibodies, thymoma associations, edrophonium testing, cholinergic versus myasthenic crisis, and immunosuppressive treatment options. Peripheral neuropathy and diabetic neuropathy are examined with focus on pathophysiology (hyperglycemia, ischemia, oxidative stress, inflammatory damage), stocking-glove pattern presentation, monofilament testing, nerve conduction studies, EMG interpretation, pharmacologic symptom management (gabapentin, pregabalin, tricyclic antidepressants), TENS therapy, and strict glycemic control as the cornerstone of prevention. The material integrates clinical manifestations, diagnostic testing, pharmacologic interventions, non-pharmacologic therapies, and long-term management strategies essential for advanced pathophysiology mastery. The content aligns closely with Pathophysiology: The Biologic Basis for Disease in Adults and Children by McCance and Huether, a primary textbook used in graduate-level advanced pathophysiology courses. Concepts reflect system-based neurologic dysfunction, autoimmune mechanisms, genetic influences, and evidence-based therapeutic interventions emphasized in MSN and nurse practitioner curricula. This document is particularly relevant for: Students enrolled in NR 507 Advanced Pathophysiology MSN and nurse practitioner students RN-to-MSN students studying neurologic disorders Nursing students preparing for cumulative neurologic system exams Healthcare students reviewing neurodegenerative and neuromuscular disease mechanisms It serves as a structured, exam-focused study guide designed to strengthen understanding of neurologic pathophysiology, diagnostic interpretation, pharmacologic management, and interdisciplinary care strategies for complex neurologic disorders. Keywords: NR 507 Edapt Week 7 advanced pathophysiology neurology Alzheimer disease amyloid beta tau APOE epsilon 4 risk Parkinson disease dopamine deficiency levodopa carbidopa therapy Multiple sclerosis McDonald criteria MRI T2 lesions MS Guillain Barre syndrome IVIG plasmapheresis albuminocytologic dissociation myasthenia gravis AChR antibodies cholinergic crisis symptoms peripheral neuropathy causes diabetic neuropathy stocking glove pattern monofilament test diabetic foot gabapentin pregabalin neuropathic pain